Variant report
Variant | nsv1035391 |
---|---|
Chromosome Location | chr12:34482900-34730341 |
allele | n/a |
Outlinks | Ensembl   UCSC |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:34460200-34512800 | ZNF genes & repeats | ES-UCSF4 Cell Line | embryonic stem cell |
2 | chr12:34463800-34486200 | ZNF genes & repeats | Fetal Adrenal Gland | Adrenal Gland |
3 | chr12:34473600-34489600 | ZNF genes & repeats | Monocytes-CD14+_RO01746 | blood |
4 | chr12:34480400-34559800 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
5 | chr12:34484200-34488800 | ZNF genes & repeats | Foreskin Melanocyte Primary Cells skin01 | Skin |
6 | chr12:34486200-34487000 | Enhancers | K562 | blood |
7 | chr12:34486400-34487600 | Bivalent Enhancer | Placenta | Placenta |
8 | chr12:34486400-34488000 | ZNF genes & repeats | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
9 | chr12:34487000-34487800 | Weak transcription | K562 | blood |
10 | chr12:34487800-34488000 | Bivalent/Poised TSS | A549 | lung |
11 | chr12:34487800-34488600 | Active TSS | K562 | blood |
12 | chr12:34488000-34488400 | Flanking Bivalent TSS/Enh | A549 | lung |
13 | chr12:34488400-34489000 | Bivalent/Poised TSS | A549 | lung |
14 | chr12:34488400-34489200 | Bivalent/Poised TSS | ES-I3 Cell Line | embryonic stem cell |
15 | chr12:34488600-34488800 | Flanking Active TSS | K562 | blood |
16 | chr12:34488600-34489000 | Bivalent Enhancer | ES-WA7 Cell Line | embryonic stem cell |
17 | chr12:34488800-34489000 | Active TSS | K562 | blood |
18 | chr12:34488800-34490600 | Bivalent Enhancer | Placenta | Placenta |
19 | chr12:34489000-34490600 | Flanking Bivalent TSS/Enh | A549 | lung |
20 | chr12:34489000-34490600 | Flanking Active TSS | K562 | blood |
21 | chr12:34489800-34490200 | Bivalent/Poised TSS | HepG2 | liver |
22 | chr12:34490600-34490800 | Enhancers | K562 | blood |
23 | chr12:34490600-34491200 | Bivalent Enhancer | A549 | lung |
24 | chr12:34491400-34492600 | ZNF genes & repeats | Foreskin Fibroblast Primary Cells skin01 | Skin |
25 | chr12:34491600-34492200 | Active TSS | H1 Derived Mesenchymal Stem Cells | ES cell derived |
26 | chr12:34491600-34498400 | ZNF genes & repeats | Foreskin Melanocyte Primary Cells skin01 | Skin |
27 | chr12:34492200-34492400 | Bivalent Enhancer | Primary T cells fromperipheralblood | blood |
28 | chr12:34492200-34493600 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
29 | chr12:34492400-34493200 | Bivalent Enhancer | A549 | lung |
30 | chr12:34492800-34496000 | ZNF genes & repeats | Breast Myoepithelial Primary Cells | Breast |
31 | chr12:34493200-34494200 | Flanking Bivalent TSS/Enh | A549 | lung |
32 | chr12:34493800-34494400 | Bivalent Enhancer | Placenta | Placenta |
33 | chr12:34493800-34495000 | Flanking Active TSS | K562 | blood |
34 | chr12:34494000-34494400 | Bivalent/Poised TSS | ES-WA7 Cell Line | embryonic stem cell |
35 | chr12:34494200-34494600 | Bivalent/Poised TSS | A549 | lung |
36 | chr12:34494600-34495800 | Flanking Bivalent TSS/Enh | A549 | lung |
37 | chr12:34495000-34496000 | Active TSS | K562 | blood |
38 | chr12:34495200-34499400 | Bivalent Enhancer | Placenta | Placenta |
39 | chr12:34495800-34496000 | Bivalent/Poised TSS | A549 | lung |
40 | chr12:34496000-34496600 | Active TSS | A549 | lung |
41 | chr12:34496000-34497600 | Weak transcription | K562 | blood |
42 | chr12:34496600-34498400 | Weak transcription | A549 | lung |
43 | chr12:34497400-34512800 | ZNF genes & repeats | Fetal Stomach | stomach |
44 | chr12:34497600-34499000 | Enhancers | K562 | blood |
45 | chr12:34498400-34499200 | Bivalent/Poised TSS | HepG2 | liver |
46 | chr12:34498400-34500800 | Active TSS | A549 | lung |
47 | chr12:34498600-34504400 | ZNF genes & repeats | Monocytes-CD14+_RO01746 | blood |
48 | chr12:34498800-34500200 | ZNF genes & repeats | Breast Myoepithelial Primary Cells | Breast |
49 | chr12:34499000-34499800 | Flanking Active TSS | K562 | blood |
50 | chr12:34499200-34500000 | Flanking Bivalent TSS/Enh | HepG2 | liver |